Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001104659-22-071472

Options or other derivatives

  • Director acquired 14,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +14,500 14,500 I
Loading xslF345X03/tm2218398-2_4seq1.xml…